Cochrane Abstracts
Opioid agonist therapy for opioid use disorder in primary versus specialty care
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Opioid Agonist Therapy for Opioid Use Disorder in Primary Versus Specialty Care." Cochrane Abstracts, John Wiley & Sons, Inc, 2026. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/440819/all/Opioid_agonist_therapy_for_opioid_use_disorder_in_primary_versus_specialty_care.
Opioid agonist therapy for opioid use disorder in primary versus specialty care. Cochrane Abstracts. John Wiley & Sons, Inc; 2026. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440819/all/Opioid_agonist_therapy_for_opioid_use_disorder_in_primary_versus_specialty_care. Accessed February 8, 2026.
Opioid agonist therapy for opioid use disorder in primary versus specialty care. (2026). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/440819/all/Opioid_agonist_therapy_for_opioid_use_disorder_in_primary_versus_specialty_care
Opioid Agonist Therapy for Opioid Use Disorder in Primary Versus Specialty Care [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2026. [cited 2026 February 08]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/440819/all/Opioid_agonist_therapy_for_opioid_use_disorder_in_primary_versus_specialty_care.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Opioid agonist therapy for opioid use disorder in primary versus specialty care
ID - 440819
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/440819/all/Opioid_agonist_therapy_for_opioid_use_disorder_in_primary_versus_specialty_care
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
